Introduction: Management of carbapenem resistant Acinetobacter baumannii infections in intensive care units is challenging because of few treatment options and poor outcomes. In order to contribute to patients' survival, the factors related to mortality in these infections were evaluated in this study
Ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contributed to high mort...
Since the beginning of the COVID-19 pandemic, the impact of superinfections in intensive care units ...
Background/PurposeVentilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contri...
Introduction: Management of carbapenem resistant Acinetobacter baumannii infections in intensive car...
A retrospective case–control study was performed to assess risk factors and the clinical and economi...
Introduction: Acinetobacter baumannii is considered to be a nosocomial pathogen gradually becoming m...
This study was performed to compare the mortality associated with carbapenem-resistant Acinetobacter...
Purpose. This study was aimed to identify the determinants of in-hospital mortality in Acinetobacter...
Background/PurposeIdentification of risks of mortality for carbapenem-resistant Acinetobacter bauman...
Objectives This study aimed at identifying risk factors for the acquisition of carbapenem-resistant ...
Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hosp...
© 2016 Djordjevicet al. Introduction: Acinetobacter baumannii is one of major causative agents of se...
SummaryBackgroundRisk factors and outcome in patients who acquire nosocomial infections due to carba...
Acinetobacter baumannii has emerged as an increasing-ly common cause of nosocomial infections in the...
Although initially considered of low pathogenic potential in healthy individuals, Acintobacter bauma...
Ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contributed to high mort...
Since the beginning of the COVID-19 pandemic, the impact of superinfections in intensive care units ...
Background/PurposeVentilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contri...
Introduction: Management of carbapenem resistant Acinetobacter baumannii infections in intensive car...
A retrospective case–control study was performed to assess risk factors and the clinical and economi...
Introduction: Acinetobacter baumannii is considered to be a nosocomial pathogen gradually becoming m...
This study was performed to compare the mortality associated with carbapenem-resistant Acinetobacter...
Purpose. This study was aimed to identify the determinants of in-hospital mortality in Acinetobacter...
Background/PurposeIdentification of risks of mortality for carbapenem-resistant Acinetobacter bauman...
Objectives This study aimed at identifying risk factors for the acquisition of carbapenem-resistant ...
Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hosp...
© 2016 Djordjevicet al. Introduction: Acinetobacter baumannii is one of major causative agents of se...
SummaryBackgroundRisk factors and outcome in patients who acquire nosocomial infections due to carba...
Acinetobacter baumannii has emerged as an increasing-ly common cause of nosocomial infections in the...
Although initially considered of low pathogenic potential in healthy individuals, Acintobacter bauma...
Ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contributed to high mort...
Since the beginning of the COVID-19 pandemic, the impact of superinfections in intensive care units ...
Background/PurposeVentilator-associated pneumonia (VAP) caused by Acinetobacter baumannii has contri...